/

Sociétés

4M

Non vérifié

4Moving Biotech

Ce que nous écrivons

BiotechnologieFitness/Bien-êtreIndustrieIndustrie pharmaceutiqueSanté

4 communiqués de presse

Voir tous les communiqués de presse

08/01/2026

4Moving Biotech Receives FDA IND Clearance for 4P004, Strengthening Its Position as a Leading Innovator in Disease-Modifying Osteoarthritis Therapeutics

Source

4Moving Biotech

Émetteur

1.00

0

16/07/2025

Science

Santé Publique

Industrie pharmaceutique

Fitness/Bien-être

Médecine - Divers

Biotechnologie

Santé

Industrie

4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis

Source

4Moving Biotech

Émetteur

1.00

0

27/03/2025

Health Canada Authorizes 4Moving Biotech to Launch Phase 2a INFLAM MOTION Clinical Trial for Knee Osteoarthritis

Source

4Moving Biotech

Émetteur

1.00

0

02/07/2024

4Moving Biotech welcomes Luc Boblet as Chief Executive Officer to lead next phase of growth

Source

4Moving Biotech

Émetteur

1.00

0

Followers

0

Compatibilité

0